Switzer TV

 

In our last episode of 2025, we get the heavy hitters. This week on Switzer Investing TV, Peter Switzer sits down with three seasoned market pros to cut through the noise and talk straight about where the real growth opportunities may lie heading into 2026.

With tech stocks sold off, resources rotating back into favour, and AI fears dominating headlines, each guest lays out what they’d actually buy now and why.

Adam Dawes kicks things off by explaining why selective commodities, developers and beaten-up growth names are back on the radar, and where investors need to be careful.

Jun Bei Liu then shares her “buy low” Christmas gift ideas, focusing on high-quality growth companies that have fallen out of favour but continue to grow earnings. Finally, Paul Rickard wraps up the year with a pragmatic take on oversold tech, patience, and which names could reward investors willing to look past short-term fear.

Interview timecodes:

00:01:01 - Adam Dawes, Shaw and Partners

00:17:41 - Jun Bei Liu, TenCap

00:25:37 - Paul Rickard, Switzer Report

 

This is our last show for 2025. We thank you for joining us and we'll see you on 10 January, 2026 with a new year of Switzer Investing TV.

Switzer Investing TV (15/12/25): What would our experts invest in now for growth in 2026?

In our last episode of 2025, we get the heavy hitters. This week on Switzer Investing TV, Peter Switzer sits down with three seasoned market pros to cut through the noise and talk straight about where the real growth opportunities may lie heading into 2026.

More videos

My knee replacement

Dr Ross Walker shares his own experience of having a total knee replacement.

Series: ,
Mad about Money Live

Tune in to find out the latest money and market news with Peter Switzer and Paul Rickard.

Series: ,
We pinpoint some tech stocks you don't want to ignore!

Peter Switzer is joined by Burman Invest's Julia Lee, Medallion's Michael Wayne, Tribeca's Jun Bei Liu and Switzer's Paul Rickard.

Series: ,
The link between COVID-19 and heart disease

Dr Ross Walker looks at whether there is any connection between the Coronavirus and drugs used to treat cardiovascular disease.

Series: ,
Mad about Money Live

Join Peter Switzer and Paul Rickard for their take on the latest money and market news.

Series: ,
Is Mesoblast the biomedical stock you have to have? + Freelancer: stock on the way up?

Peter Switzer is joined by Burman Invest's Julia Lee, Freelancer.com's Matt Barrie, Vanguard's Robin Bowerman and Switzer's Paul Rickard.

Series: ,
What is a viral load?

Dr Ross Walker looks at viral load in relation to COVID-19 and which people are most at risk.

Series: ,
Mad about Money Live

Tune in to the latest live episode of Mad about Money with Peter Switzer and Paul Rickard.

Series: ,
Tech stocks on the slide! Which stocks are the best buys?

On this week's show, Peter Switzer is joined by Shaw and Partners' Adam Dawes, Burman Invest's Julia Lee, Tribeca Investment Partners' Jun Bei Liu and Switzer's Paul Rickard.

Series: ,
How to boost your immunity

Dr Ross Walker explains how you can boost your immunity and which vitamins will give you an extra boost.

Series: ,
Mad about Money Live

Join Peter Switzer and Paul Rickard for their take on the latest money and market news.

Series: ,
7 Experts! Their One Best Stock! Plus, CEO of NextDC - Check Out The Future!

Peter Switzer talks to the experts about the best companies coming out of reporting season, plus NextDC CEO Craig Scroggie.

Series: ,
1 40 41 42 43 44 51

Fill in the form below to subscribe to Switzer Daily and get our latest articles, videos and podcasts sent straight to your inbox

Get the latest financial, business, and political expert commentary delivered to your inbox.

When you sign up, we will never give away or sell or barter or trade your email address.

And you can unsubscribe at any time!
Subscribe
© 2006-2021 Switzer. All Rights Reserved. Australian Financial Services Licence Number 286531. 
shopping-cartphoneenvelopedollargraduation-cap linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram